[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-352427-105":59,"doc-detail-352427-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","optimal-control-theory-as-a-method-for-designing-multidrug-adaptive-therapy-regimens-article","Optimal control theory as a method for designing multidrug adaptive therapy regimens - Article","","Evolutionarily informed cancer treatment regimens aim to limit the development of drug resistance, yet their design is often complex. This work uses optimal control theory to guide a two-drug adaptive therapy regimen based on a logistic differential equation model of tumors with four resistantness-diverse subpopulations. Regimens that maintain competition between resistant and sensitive populations performed best, remained robust across parameters, and outperformed standard-of-care in predicted future in vitro performance.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/optimal-control-theory-as-a-method-for-designing-multidrug-adaptive-therapy-regimens-article/352427/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/optimal-control-theory-as-a-method-for-designing-multidrug-adaptive-therapy-regimens-article/352427.png","ImageObject",300,407,{"name":92,"@type":93},"Levi","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"How does the document propose designing multidrug adaptive therapy regimens?","Question",{"text":112,"@type":113},"It applies optimal control theory (OCT) to guide the design of a two-drug adaptive therapy regimen, starting from a tumor differential equation model with multiple subpopulations.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What tumor model is used in the study?",{"text":117,"@type":113},"The study uses a logistic differential equation model of a tumor composed of four populations with different resistance levels to two drugs.",{"name":119,"@type":110,"acceptedAnswer":120},"What regimen strategy performed best according to the results?",{"text":121,"@type":113},"Regimens that prioritized maintaining competition between resistant and sensitive populations performed best, and this advantage was robust across model parameters.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},352427,1790195371,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},7971461740909,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","npj | systems biology and applications Article  \n\n| Published in partnership with the Systems Biology Institute |  | |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41540-025-00613-y](https://doi.org/10.1038/s41540-025-00613-y) |  |  |\n| Optimal control theory as a method for designing multidrug adaptive therapy regimens\u003Cbr> Check for updates |  |  |\n| Afton Widdershins1, Elsa Hansen2, Andrew Read2 & Raymond Hohl1  |  |  |\n| Evolutionarily informed regimens offer new approaches that hope to combat the development of resistance during cancer treatment. These regimens are often complicated to design. In this work, we use optimal control theory(OCT)to guidethe design of a two-drug adaptive therapy regimen. We begin with a logistic differential equation model of a tumor composed of four populations with different resistance to two drugs. OCT analysis identiﬁed rules regarding regimen creation. We simulated various regimen designs, and we found that regimens prioritizing maintenance of competition between resistant and sensitive populations performed the best. Results were robust across parameters, indicating that the ability to maintain competition was more important than the technique used. With regimens identiﬁed, we compared them to practical and standard-of-care regimens to predict future in vitro performance. Practical regimens still outperform standard-of-care for nearly all parameters. As such, OCT offers one avenue for exploring multidrug adaptive regimen design. |  |  |\n| Cancer treatment failure due to the development of resistance remains asigniﬁcant challenge to patient recovery. Acquired resistance to treatment is often attributed to cancer’ssigniﬁcant ability to adapt and evolve in response to changing environmental conditions1. This is often driven by the presence of tumor heterogeneity, whether present at the beginning of treatment or derived from the genetic instability noted as a hallmark of malignancy2–7. Selective pressures can then inﬂuence the most successful cell populations within a tumor. Asan example, chemotherapy can act asa selective pressure by killing susceptible cells and allowing resistant populations to expand8.\u003Cbr>Traditional cancer treatment regimens focus on maximal cell killing, with the goal of eradicating the cell burden present in the patient. However, these regimens rarely consider how the evolutionary and ecological dynamicsofthe tumor will respond beyond switching to the next therapy inline when the present drug fails9. Resistance is especially prevalent when maximal cell killing regimens are applied to tumors that already have existing drug resistance. Even classic techniques to combat resistance, like chemotherapy combinations, can drive the development ofworse resistance through the action of evolution10.\u003Cbr>Since the recognition of evolution as an important and underconsidered aspect of cancer treatment, regimen design paradigms that attempt to incorporate or even take advantage of evolutionary dynamics have been developed. Adaptive therapy, as one such treatment pattern, attempts to utilize intra-tumor competition in order to control the disease asa whole and delay the development of untreatable resistance11. This is | accomplished through balancing the maintenance of a large enough population of chemotherapy-susceptible cells that can compete with chemotherapy-resistant cells with the need to keep total cell burden tolerable for the patient. By maintaining the existence of susceptible cells, the growth of the resistant cells is constrained and development of clinically meaningful resistance is delayed. Adaptive therapyhas proved beneﬁcialina phase I trial (NCT02415621) for metastatic castration resistant prostate cancer, and in pre-clinical studies of ovarian cancer12, 13. While adaptive therapy has promise as a novel, evolution-based treatment paradigm, there remain a number of unanswered questions in the ﬁeld, such as the use of multiple drugs in an adaptive plan and how best to","cbCaibWTHY6yDUq8","https://ap.wps.com/l/cbCaibWTHY6yDUq8","pdf",1869622,14,"English","# Introduction\n# Adaptive therapy and evolutionary dynamics\n# Optimal control theory for regimen design\n# Modeling approach and simulations\n# Results and comparison to standard regimens","[{\"question\":\"How does the document propose designing multidrug adaptive therapy regimens?\",\"answer\":\"It applies optimal control theory (OCT) to guide the design of a two-drug adaptive therapy regimen, starting from a tumor differential equation model with multiple subpopulations.\"},{\"question\":\"What tumor model is used in the study?\",\"answer\":\"The study uses a logistic differential equation model of a tumor composed of four populations with different resistance levels to two drugs.\"},{\"question\":\"What regimen strategy performed best according to the results?\",\"answer\":\"Regimens that prioritized maintaining competition between resistant and sensitive populations performed best, and this advantage was robust across model parameters.\"}]","Optimal control theory as a method for designing multidrug adaptive therapy regimens - Article | PDF",1790099540,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1b139ba66fff082e33336229ddfc51bb.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a30c00f6414a493f05bb8b568fba1e92.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5daa924edadfec58e199e3c9832a20c6.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5a1b889d33d6587f615dca34dafa1905.webp",980,1301]